Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
7,798 total articles
Toll Brothers, a leading US luxury home builder, announced its upcoming community Shallowford Pointe in East Cobb, Marietta, GA. The development will feature upscale single-family homes with resort-style amenities and proximity to top-rated schools, expected to begin sales in late 2026.
Independent Bank Corporation announced it will release its first quarter 2026 financial results on April 23, 2026. The company will hold a conference call the same day to review the quarterly results with investors and analysts. The bank provides a broad range of financial services across Michigan's Lower Peninsula and operates with total assets of…
AH Realty Trust has sold two multifamily notes for $63 million as part of its strategic exit from real estate financing, aiming to simplify its platform and focus on core retail and office assets. The company plans to use proceeds to pay down debt and support its share repurchase program, having already repurchased approximately 3.6 million shares …
Jiayin Group Inc., a leading Chinese fintech platform, announced its Q4 and full-year 2025 unaudited financial results. The Q4 showed a decline in loan facilitation volume and net income due to tightened industry liquidity and new regulatory frameworks prioritizing compliance and asset quality. However, full-year results reflected growth in loan fa…
LENSAR, Inc., a US-based medical technology company specializing in robotic laser cataract surgery systems, announced its Q4 and full-year 2025 financial results. The company grew its ALLY robotic laser system installed base by 48% in 2025 and increased recurring revenue by 15%, reaching over $46.3 million. Although total revenue decreased slightly…
Fennec Pharmaceuticals announced the approval and grant of 377,500 incentive stock options to 24 new non-executive employees as inducements under Nasdaq Listing Rule 5635(c)(4). The grants are intended to attract talent to support commercialization efforts of their approved product PEDMARK® (PEDMARQSI® in Europe), a drug designed to mitigate platin…
NervGen Pharma Corp. (NASDAQ: NGEN) reported financial results for full year 2025 alongside significant clinical progress on their lead neuroreparative therapeutic NVG-291 for chronic tetraplegia. The company completed an End-of-Phase 2 FDA meeting and plans a Phase 3 trial initiation in mid-2026, following positive Phase 1b/2a data demonstrating m…
Super Hi International Holding Ltd. (NASDAQ: HDL), operator of Haidilao hot pot restaurants internationally, announced unaudited Q4 and full year 2025 financial results showing 10.2% revenue growth in Q4 and 8.0% for the full year. Total Haidilao restaurants increased to 126 globally. Strong guest visit growth supports revenue increases across core…
BrightSpring Health Services has finalized the sale of its ResCare Community Living division to Sevita. This strategic move allows BrightSpring to concentrate on expanding its Provider Services division, including home health care and rehabilitation services. The sale aims to ensure continuity of care and operational stability for individuals with …
Sound Group Inc., a Nasdaq-listed global AI-powered audio company, announced unaudited financial results for the second half and full year of 2025. The company posted a 53% increase in net revenues to US$443.7 million and a return to profitability with a net income of US$31.6 million for the year. Growth was driven by expansion of value-added audio…
T1 Energy Inc. (NYSE: TE) announced its fourth quarter and full-year 2025 financial results, highlighting significant progress in the construction of its G2_Austin 2.1 GW solar cell fab, on track for Q4 2026 production start. The company achieved record quarterly module production and sales at its G1_Dallas facility in Q4 2025, expanded utility-sca…
AGA Precision Systems, a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), has signed a long-term agreement to supply mission-critical aerospace and defense components to Turbo-Jet Products. The agreement spans an initial five years with options for renewal, reinforcing AGA's strategic role in the aerospace and defense supply chain, supported by its…
InflaRx N.V., a biopharmaceutical company specializing in anti-inflammatory therapeutics targeting the complement system, announced its participation in the Raymond James 2026 Biotech Innovation Symposium. The company will hold individual investor meetings during the event to discuss its ongoing programs, including its oral small molecule izicopan …
MiNK Therapeutics reported their Q4 and full-year 2025 financial results, highlighting significant progress in their iNKT cell therapy pipeline targeting severe immune-mediated diseases such as ARDS, pulmonary fibrosis, cancer, and GVHD. The company secured non-dilutive funding from collaborations and grants, advanced multiple clinical programs, an…
Legato Merger Corp. III disclosed that its audited financial statements contain a going concern explanatory paragraph by its independent auditors, as previously reported. The company reiterated no changes to its financial statements and highlighted the pending business combination with Einride AB, expected to close in the first half of 2026, which …
BOS Better Online Solutions Ltd. (BOSC) reported record revenue and net income for the full year 2025, driven by strong growth in its Supply Chain and Intelligent Robotics divisions despite continuing geopolitical tensions affecting its RFID division. The company projects stable revenue and net income for 2026, reflecting operational discipline and…
Palvella Therapeutics provided its full year 2025 financial results and updated on its clinical development programs. The company announced positive Phase 3 SELVA study results for QTORIN™ rapamycin for microcystic lymphatic malformations with plans to submit an NDA in the second half of 2026 and potential FDA approval in early 2027. Additional Pha…
Old National Bancorp, a leading Midwest-based commercial bank, announced its schedule for the first-quarter 2026 earnings release on April 22, followed by a conference call. The company offers a replay of the call on its investor relations website. With $72 billion in assets, Old National serves the Midwest and Southeast and provides commercial ban…
Friedman Industries, a Texas-based metals processing and pipe manufacturing company, announced a cash dividend of $0.04 per share to be paid on May 22, 2026. This marks the company's 217th consecutive quarterly dividend since going public in 1972, reflecting its commitment to returning value to shareholders. The Board reviews dividends quarterly, a…
Milestone Scientific Inc. reported modest revenue growth and significantly reduced operating losses in 2025, highlighting a strategic shift from restructuring to growth under new leadership. The company anticipates double-digit revenue growth in 2026, driven by a 400% increase in CompuFlo sales, expansion in dental and medical segments, and improve…
KULR Technology Group, Inc. reported its fourth quarter and full-year 2025 financial results, highlighting a 51% increase in full-year revenue driven by growth in product sales and expanded customer relationships. Despite revenue gains, the company posted a substantial net loss for the year, largely due to a $28 million mark-to-market bitcoin loss …
Alvotech, a biotechnology firm specializing in biosimilar medicines, has filed its 2025 Annual Report with the U.S. SEC. The report highlights the company's portfolio of approved biosimilars and an active pipeline targeting multiple therapeutic areas, supported by strategic global partnerships for market expansion.
Alvotech, a Nasdaq-listed biotechnology firm specializing in biosimilars, has published its 2025 Annual Report. The company continues its focus on developing and commercializing high-quality biosimilar medicines globally, with five biosimilars already approved and marketed. Their pipeline includes nine biosimilar candidates targeting multiple thera…
Curanex Pharmaceuticals reports significant progress in manufacturing, toxicology, intellectual property, and regulatory preparations for its lead drug candidate Phyto-N, targeting ulcerative colitis. The company completed GMP pilot batch production and pivotal toxicology studies, aiming for an IND submission by late 2026 and plans to initiate Phas…
Future Money Acquisition Corporation, a Cayman Islands-based blank check company, successfully completed its IPO by offering 11.2 million units at $10 each, including a partial exercise of the underwriters' overallotment option. The company raised gross proceeds of $112 million and concurrently closed a private placement for an additional $3 millio…
